Inaktiver Wert

Andere Sprachen SciBase Holding AB (publ)

Aktien

Schlusskurs Nasdaq Stockholm Andere Börsenplätze
- ^SEK	-

05.04.	SciBase plant Kapitalerhöhung in Höhe von 48 Millionen SEK für Kommerzialisierung und Wachstum in den USA	MT
28.02.	SciBase bietet Diagnosewerkzeug auf der Skinobs-Plattform für Kosmetiktests an	MT

SciBase Partners with Al Shirawi Healthcare solutions to Offer Nevisense in UAE	24.04.
SciBase will present at the Redeye Medtech Event on April 24[th]	23.04.
Today is the first day of the subscription period in SciBase rights issue	23.04.
SciBase publishes prospectus in connection with upcoming rights issue	19.04.
Notice to extraordinary general meeting in Scibase Holding AB (publ)	08.04.
SciBase Plans SEK48 Million Capital Raising for Commercialization, Growth in US	05.04.
SciBase resolves on a directed issued of approximately SEK 33 million and a rights issue of approximately SEK 15 million	05.04.
SciBase to Offer Diagnostic Tool on Skinobs Cosmetic Testing Platform	28.02.
SciBase Partners with Skinobs to Offer Nevisense on Global Cosmetic Testing Platform	28.02.
Scibase Q4’23 - Investments for future growth	22.02.
Year-end report	21.02.
Keynote speakers presented Nevisense at the 2024 Winter Clinical Dermatology Conference in Miami	19.02.
New study shows Nevisense evaluates skin barrier function with less sensitivity to lifestyle factors than TEWL	16.02.
Sweden's Scibase Partners with Inderes for Equity Research	30.01.
SciBase initiates collaboration with Inderes for commissioned research	30.01.
Welcome to SciBase Capital Markets Day 2024	26.01.
Letter from the CEO	10.01.
Welcome to SciBase Capital Markets Day 2024	09.01.
SciBase capital markets day 2024 - save the date	28.12.
Skin Cancer and Reconstructive Surgery Center of California Adopts AI-driven Nevisense for early skin cancer detection	04.12.

Keine Ergebnisse zu dieser Suche